Immunocore
Dan Holding has extensive experience in finance and revenue management, currently serving as Associate Director of Revenue & O2C at Immunocore from April 2022 to June 2025. Prior to this role, Dan held several positions at Immunocore, including Senior Manager of Finance and Commercial Finance Manager. Dan's previous experience includes working as a Senior Finance Analyst at McLaren Group from February 2019 to September 2020, and over eight years at Eli Lilly and Company, where positions included UK Finance Analyst, Financial Planning Associate, and Supply Chain Analyst/Senior Customer Support Representative.
This person is not in any teams
This person is not in any offices
Immunocore
1 followers
Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.